{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:17:27Z","timestamp":1783394247127,"version":"3.54.6"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.urolonc.2024.12.276","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T12:14:57Z","timestamp":1736597697000},"page":"331.e9-331.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immediate second resection versus restage transurethral resection of bladder tumor: A prospective randomized clinical trial (IMMERSE trial)"],"prefix":"10.1016","volume":"43","author":[{"given":"Shritosh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-8626","authenticated-orcid":false,"given":"Rishi","family":"Nayyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlesh","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2024.12.276_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00428-015-1739-2","article-title":"Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old","volume":"466","author":"Comp\u00e9rat","year":"2015","journal-title":"VirchowsArchiv"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0003","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","article-title":"Detrusor muscle in the first, apparently complete transurethral resection of bladder tumor specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience","volume":"57","author":"Mariappan","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bju.13354","article-title":"The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade\/grade 3 bladder cancer treated with bacille Calmette\u2013Gu\u00e9rin","volume":"118","author":"Gontero","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0005","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s13193-022-01516-8","article-title":"When to avoid a restaging procedure for non-muscle invasive bladder cancer? Inferences from a tertiary care center","volume":"13","author":"Bhirud","year":"2022","journal-title":"Ind J Surg Oncol"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0006","unstructured":"Gontero P., Comp\u00e9rat E., Dominguez J.L., Liedberg F., Mariappan P., Masson-Lecomte A., et al. Non-muscle-invasive bladder cancer (TaT1 and CIS) EAU Guidelines. 2023. https:\/\/uroweb.org\/guidelines\/non-muscle-invasive-bladder-cancer. (Accessed on 11 Sept 2023)."},{"key":"10.1016\/j.urolonc.2024.12.276_bib0007","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/end.2011.0576","article-title":"Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor","volume":"26","author":"Kim","year":"2012","journal-title":"J Endourol"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0008","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.kjms.2016.02.002","article-title":"Can immediate second resection be an alternative to standardized second transurethral resection of bladder tumors?","volume":"32","author":"Do\u01e7antekin","year":"2016","journal-title":"Kaohsiung J Med Sci"},{"issue":"4S","key":"10.1016\/j.urolonc.2024.12.276_bib0009","first-page":"e720","article-title":"The impact of early re-resection on upstaging and upgrading in patients with high grade non-muscle invasive bladder cancer","volume":"187","author":"Vasdev","year":"2012","journal-title":"J Urol [Internet]"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/0974-7796.140990","article-title":"Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer","volume":"6","author":"Gill","year":"2014","journal-title":"Urol Ann"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0011","first-page":"650","article-title":"Long-term outcomes from re-resection for high-risk non\u2013muscle-invasive bladder cancer: a potential to rationalize use","volume":"5","author":"Gordon","year":"2019","journal-title":"EurUrol Focus"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0012","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000350512","article-title":"Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: iis it a risk factor for residual tumor detection?","volume":"91","author":"S\u00fcer","year":"2013","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2024.12.276_bib0013","first-page":"20","article-title":"The effect of second TURBT on recurrence and progression in primary Ta high-grade bladder cancers: a multicenter clinical trial comparing long-term outcomes","volume":"22","author":"Mi\u00e7oo\u011fullar\u0131","year":"2023","journal-title":"Bullet Uro oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924010561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924010561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T16:02:58Z","timestamp":1746892978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924010561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1078143924010561"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.12.276","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immediate second resection versus restage transurethral resection of bladder tumor: A prospective randomized clinical trial (IMMERSE trial)","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.12.276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}